Stock Information
Larimar Therapeutics Inc (LRMR)
Ticker Symbol: LRMR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $332.43 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.0803
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -134.14%
Latest News
-
Baird Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $5
Tue, Jun 30, 2026 7:48 AM
-
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's Ataxia Transcript
Mon, Jun 29, 2026 1:52 PM
-
Get insights into the top gainers and losers of Monday's pre-market session.
Mon, Jun 29, 2026 12:30 PM
-
Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug
Mon, Jun 29, 2026 10:15 AM
-
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Mon, Jun 29, 2026 8:11 AM
-
12 Health Care Stocks Moving In Monday's Pre-Market Session
Mon, Jun 29, 2026 8:05 AM
-
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket
Mon, Jun 29, 2026 7:03 AM
-
Larimar Therapeutics Submits First Module Of Rolling BLA Submission To FDA For Accelerated Approval Of Nomlabofusp; Remaining Modules Expected To Be Submitted In H2 2026
Mon, Jun 29, 2026 6:32 AM
-
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
Fri, Jun 26, 2026 8:05 PM
Key Financials
Financial data not available
